Skip to main content

Table 4 Differences between NAC and Placebo and CT versus Placebo on the clinical and patient measures of improvement

From: A randomised controlled trial of a mitochondrial therapeutic target for bipolar depression: mitochondrial agents, N-acetylcysteine, and placebo

  1. Note: CGI-I, Clinical Global Impressions - Improvement; PGI-I, Patient Global Impression - Improvement
Back to article page

BMC Medicine

ISSN: 1741-7015

Contact us